Pluripotent possibilities: human umbilical cord blood cell treatment after neonatal brain injury
- PMID: 23583051
- DOI: 10.1016/j.pediatrneurol.2012.10.010
Pluripotent possibilities: human umbilical cord blood cell treatment after neonatal brain injury
Abstract
Perinatal hypoxic-ischemic brain injury and stroke in the developing brain remain important causes of chronic neurologic morbidity. Emerging data suggest that transplantation of umbilical cord blood-derived stem cells may have therapeutic potential for neuroregeneration and improved functional outcome. The pluripotent capacity of stem cells from the human umbilical cord blood provides simultaneous targeting of multiple neuropathologic events initiated by a hypoxic-ischemic insult. Their high regenerative potential and naïve immunologic phenotype makes them a preferable choice for transplantation. A multiplicity of transplantation protocols have been studied with a variety of brain injury models; however, only a few have been conducted on immature animals. Biological recipient characteristics, such as age and sex, appear to differentially modulate responses of the animals to the transplanted cord blood stem cells. Survival, migration, and function of the transplanted cells have also been studied and reveal insights into the mechanisms of cord blood stem cell effects. Data from preclinical studies have informed current clinical safety trials of human cord blood in neonates, and further work is needed to continue progress in this field.
Copyright © 2013. Published by Elsevier Inc.
Similar articles
-
Stem cell therapy for neonatal brain injury.Clin Perinatol. 2014 Mar;41(1):133-48. doi: 10.1016/j.clp.2013.09.002. Epub 2013 Dec 12. Clin Perinatol. 2014. PMID: 24524451 Review.
-
Transplantation of human umbilical cord blood cells mediated beneficial effects on apoptosis, angiogenesis and neuronal survival after hypoxic-ischemic brain injury in rats.Cell Tissue Res. 2012 Jun;348(3):429-38. doi: 10.1007/s00441-012-1401-0. Epub 2012 Apr 18. Cell Tissue Res. 2012. PMID: 22526623
-
Umbilical cord blood mononuclear cell transplantation for neonatal hypoxic-ischemic encephalopathy.Pediatr Res. 2012 Apr;71(4 Pt 2):464-73. doi: 10.1038/pr.2011.59. Epub 2012 Feb 8. Pediatr Res. 2012. PMID: 22430382 Review.
-
Functional recovery after human umbilical cord blood cells transplantation with brain-derived neutrophic factor into the spinal cord injured rat.Acta Neurochir (Wien). 2005 Sep;147(9):985-92; discussion 992. doi: 10.1007/s00701-005-0538-y. Epub 2005 Jul 11. Acta Neurochir (Wien). 2005. PMID: 16010451
-
Human umbilical cord blood mesenchymal stem cells protect mice brain after trauma.Crit Care Med. 2011 Nov;39(11):2501-10. doi: 10.1097/CCM.0b013e31822629ba. Crit Care Med. 2011. PMID: 21725237
Cited by
-
Serum Neuron-Specific Enolase as a Biomarker of Neonatal Brain Injury-New Perspectives for the Identification of Preterm Neonates at High Risk for Severe Intraventricular Hemorrhage.Biomolecules. 2024 Apr 3;14(4):434. doi: 10.3390/biom14040434. Biomolecules. 2024. PMID: 38672451 Free PMC article.
-
Stem cell-based interventions for the treatment of stroke in newborn infants.Cochrane Database Syst Rev. 2023 Nov 23;11(11):CD015582. doi: 10.1002/14651858.CD015582.pub2. Cochrane Database Syst Rev. 2023. PMID: 37994736 Review.
-
A Biosafety Study of Human Umbilical Cord Blood Mononuclear Cells Transduced with Adenoviral Vector Carrying Human Vascular Endothelial Growth Factor cDNA In Vitro.Biomedicines. 2023 Jul 18;11(7):2020. doi: 10.3390/biomedicines11072020. Biomedicines. 2023. PMID: 37509661 Free PMC article.
-
Beyond brain injury biomarkers: chemoattractants and circulating progenitor cells as biomarkers of endogenous rehabilitation effort in preterm neonates with encephalopathy.Front Pediatr. 2023 May 24;11:1151787. doi: 10.3389/fped.2023.1151787. eCollection 2023. Front Pediatr. 2023. PMID: 37292373 Free PMC article.
-
Stem cell-based interventions for the prevention and treatment of intraventricular haemorrhage and encephalopathy of prematurity in preterm infants.Cochrane Database Syst Rev. 2023 Feb 15;2(2):CD013201. doi: 10.1002/14651858.CD013201.pub3. Cochrane Database Syst Rev. 2023. PMID: 36790019 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
